Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    IL-10R alpha Antibody (RM0101-9E12), Alexa Fluor™ 532, Novus Biologicals™
 
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Hamster Monoclonal Antibody
Supplier: Novus Biologicals NBP122459AF532
Description
IL-10R alpha Monoclonal antibody specifically detects IL-10R alpha in Mouse samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin).Specifications
| IL-10R alpha | |
| Monoclonal | |
| Alexa Fluor 532 | |
| 50 mM sodium borate with 0.05% sodium azide | |
| IL10RA | |
| Mouse recombinant protein of the Extracellular domain of IL-10R alpha | |
| 0.1 mL | |
| Primary | |
| This was produced from a hybridoma (mouse myeloma fused with spleen cells from a hamster immunized with mouse recombinant protein of extracellular domain of IL-10R alpha. | |
| Store at 4°C in the dark. | 
| Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin) | |
| RM0101-9E12 | |
| Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin | |
| CD210 antigen, CDw210a, HIL-10R, IBD28, IL-10 receptor subunit alpha, IL-10R subunit 1, IL-10R1, IL-10RA, IL10RIL-10R subunit alpha, interleukin 10 receptor, alpha, interleukin-10 receptor alpha chain, Interleukin-10 receptor subunit 1, interleukin-10 receptor subunit alpha | |
| Hamster | |
| Protein A or G purified | |
| Cytokine Research | |
| 3587.0 | |
| Mouse | |
| IgG | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction
            